West Nile Virus found in UK mosquitoes for first time - European Medical Journal

West Nile Virus found in UK mosquitoes for first time

Words by Isabel O’Brien

The UK Health Security Agency (UKHSA) and the Animal and Plant Health Agency (APHA) have confirmed the first detection of the West Nile virus (WNV) in mosquitoes collected in Britain. The news has led experts to point to the climate crisis as a potential trigger.

The virus was identified by testing two mosquitoes that were collected from wetlands near the River Idle in Nottinghamshire in July 2023. This marks the first time the virus has been detected in the UK, although both agencies stress that the risk to the general public remains very low and there is no evidence of ongoing circulation in local birds or mosquitoes.

“While this is the first detection of West Nile Virus in mosquitoes in the UK so far, it is not unexpected as the virus is already widespread in Europe,” commented Dr Meera Chand, Deputy Director, Travel Health, Zoonoses, Emerging Infections, Respiratory and Tuberculosis, UKHSA. “Vector research of this kind is designed to give us early warning of potential threats so that we can enhance our disease surveillance and control activities and ensure patients receive appropriate testing.”

WNV is a flavivirus that is primarily maintained in birds and transmitted by mosquitoes, with rare cases of transmission to humans and horses. The detection was made as part of the Vector-Borne RADAR (Real-time Arbovirus Detection And Response) programme, which has tested over 32,000 mosquitoes in total.

Dr Arran Folly, Arbovirologist, APHA, and lead of the Vector-Borne RADAR project, highlighted the broader implications: “The detection of West Nile virus in the UK is part of a wider changing landscape, where, in the wake of climate change mosquito-borne diseases are expanding to new areas. Only through continued surveillance can we assess the risk to animal and public health.”

While no locally acquired human or equine cases have been reported in the UK to date, the development underscores the importance of robust vector surveillance and diagnostic readiness as climate change continues to alter the landscape of infectious diseases in Europe.

Author:

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.